These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22115061)

  • 1. Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
    Nakayasu ES; Sobreira TJ; Torres R; Ganiko L; Oliveira PS; Marques AF; Almeida IC
    J Proteome Res; 2012 Jan; 11(1):237-46. PubMed ID: 22115061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
    Serna C; Lara JA; Rodrigues SP; Marques AF; Almeida IC; Maldonado RA
    Vaccine; 2014 Jun; 32(28):3525-32. PubMed ID: 24793944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From proteome to candidate vaccines: target discovery and molecular dynamics-guided multi-epitope vaccine engineering against kissing bug.
    Albaqami FF; Altharawi A; Althurwi HN; Alharthy KM
    Front Immunol; 2024; 15():1413893. PubMed ID: 38915396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.
    Reis-Cunha JL; Mendes TA; de Almeida Lourdes R; Ribeiro DR; Machado-de-Avila RA; de Oliveira Tavares M; Lemos DS; Câmara AC; Olórtegui CC; de Lana M; da Cunha Galvão LM; Fujiwara RT; Bartholomeu DC
    PLoS One; 2014; 9(9):e106304. PubMed ID: 25225853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
    Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
    J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
    Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C; Tzec-Arjona E; Martínez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Dumonteil E
    J Infect Dis; 2015 Jan; 211(2):258-66. PubMed ID: 25070943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
    Bhatia V; Sinha M; Luxon B; Garg N
    Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.
    Khatoon N; Ojha R; Mishra A; Prajapati VK
    Vaccine; 2018 Oct; 36(42):6290-6300. PubMed ID: 30217522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas' disease.
    Elisei RMT; Matos CS; Carvalho AMRS; Chaves AT; Medeiros FAC; Barbosa R; Marcelino AP; Dos Santos Emidio K; Coelho EAF; Duarte MC; de Oliveira Mendes TA; da Costa Rocha MO; Menezes-Souza D
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):6069-6080. PubMed ID: 29736822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.
    Mendes TA; Reis Cunha JL; de Almeida Lourdes R; Rodrigues Luiz GF; Lemos LD; dos Santos AR; da Câmara AC; Galvão LM; Bern C; Gilman RH; Fujiwara RT; Gazzinelli RT; Bartholomeu DC
    PLoS Negl Trop Dis; 2013; 7(10):e2524. PubMed ID: 24205430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Guided Discovery of Novel Class I and II
    Acevedo GR; Juiz NA; Ziblat A; Pérez Perri L; Girard MC; Ossowski MS; Fernández M; Hernández Y; Chadi R; Wittig M; Franke A; Nielsen M; Gómez KA
    J Immunol; 2020 Mar; 204(6):1571-1581. PubMed ID: 32060134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10-IFN-γ double producers CD4+ T cells are induced by immunization with an amastigote stage specific derived recombinant protein of Trypanosoma cruzi.
    Flores-García Y; Rosales-Encina JL; Satoskar AR; Talamás-Rohana P
    Int J Biol Sci; 2011; 7(8):1093-100. PubMed ID: 21927578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas Disease.
    Ros-Lucas A; Rioja-Soto D; Gascón J; Alonso-Padilla J
    Methods Mol Biol; 2023; 2673():487-504. PubMed ID: 37258934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.